Being tenacious and walking through walls
Jonathan Milner's second Invested Investor podcast details his experience as a Cambridge Angel. Since he began in 2002 he has invested in forty different companies, very often leading deals as well. In this episode he shares his most important tips learned from an extensive entrepreneurial and investing history: from shouldering the burden of turning around a company in dire straits, to simplifying the decision of who to invest in.
Jonathan, co-Founder and currently Deputy Chairman of Abcam plc, is an entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 40 companies and has assisted three technology companies to IPO on the London AIM Stock exchange.
Jonathan gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath. From 1992–95, he was a post-doctoral researcher at Bath, following which he worked at the University of Cambridge in the lab of Professor Tony Kouzarides researching the molecular basis of breast cancer. He identified the market opportunity for supplying high-quality antibodies to support protein interaction studies, and in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides.
Jonathan is also a non-executive director of Repositive, HealX and Syndicate Room. He is also Chairman of Axol Bioscience, Cambridge Allergy Therapy, and PhoreMost.
In 2015 Jonathan, with Professor Tony Kouzarides, co-founded the Milner Therapeutics Institute at the University of Cambridge. Also in 2015 he co-founded, with Professor Laurence Hurst, the Milner Institute for Evolution at the University of Bath.
Produced by Mark Cotton, Twitter.
Cambridge Angels - a leading UK business angel network with international connections.
Abcam - assay kits, reagents, and antibodies. An innovator in reagents and tools, they provide the research and clinical communities with tools and scientific support.
SyndicateRoom - connecting ambitious investors with the country’s most trailblazing companies.
The Milner Therapeutics Institute - at the University of Cambridge is dedicated to the conversion of groundbreaking science into therapies.
Milner Centre for Evolution - a unique, cross-faculty research centre at the University of Bath bridging biology, health, and education.